Integrative multi-omics reveals that downregulation of HLA-DPA1/DPB1 drives macrophage immune-metabolic dysregulation in pediatric asthma

• by Yuchen Wen, Zefan Du, Zhiyuan Zhong, Qiurong Yuan, Liangkang Lin, Ran Yao, Jiaying He, Qionghui Huang, Liang Li, Cheng Ouyang, Junbing Huang, Su Liu, Chun Chen

• June 3, 2026

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.

• by Andrea Surnit

• June 24, 2026

• 4 min

New-onset allergic diseases after SARS-CoV-2 infection: mechanistic hypotheses and emerging strategies for risk stratification

• by Encheng Li, Manying Shi, Shixiang Huang

• June 19, 2026

Assessment of Potential Drug–Drug Interactions and Associated Factors Among Pulmonary Inpatients in a Tertiary Care Hospital: A Cross-Sectional Study

• by Nim Bahadur Dangi, Hari Prasad Sapkota, Gobinda Kandel, Krishna Prasad Sapkota

• June 25, 2026